With the market opening up to foreign players, now is the time to get valuable insights into the Japanese market rules, regulations and trends. Since these can be different from the ones in your country, every year CPhI Japan hosts seminars from the government, industry associations and other important players in the market.

Register now and benefit from over 150 seminars and conferences at your disposal, informing you of all the latest trends and updates on the Japanese pharma industry!

IMPORTANT NOTE: Registration is required to attend the seminars.

The following seminars will be held in English or with interpretation:

Wednesday 20 April 2016

​T-1 | 10:45-12:00 | Free of Charge
Mergers & Acquisitions – “Growth Strategy” for Innovator Companies & Generic Industry
Dr. Gurpreet Sandhu, Managing Director, Pharmaceutical Manufacturing Corporation, Reva Pharmachem (P) Ltd.
 
K-2 | 11:00-12:30 | Free of Charge
Preparing for A FDA Foreign Drug Inspection and Data Integrity
Mr. Robert Fish, Senior Consultant, EAS Consulting Group
 
K-3 | 13:00-14:00 | Free of Charge
Conditions for foreign pharmaceutical industry to contribute to Japanese patients, market and economy
Ms. Amy Jackson, Japan Representative, Pharmaceutical Research and Manufacturers of America
 
B-2 | 11:45-12:15 | Free of Charge
International Group Presentation (Italy) - Polymorphism: opportunity or problem?
POLYCRYSTALLINE SPA
 
C-6-7 | 15:15-16:30 | Free of Charge
International Group Presentation (UK)
1. Most comprehensive global clinical supply chain solution using physical resources and supportive technologies to ensure clinical supply chain continually delivers
2. Solid Form and crystallization scale-up development in the pharmaceutical industry
1. Almac Ltd
2. Solid Form Solutions Ltd
 
T-2 | 15:00-16:30 | Free of Charge
The India-Japan Pharmaceutical Summit
The Pharma & Healthcare Industry is Changing; Its Impact & Way Forward
Organizer: PHARMEXCIL (Pharmaceutical Export Promotion Council of India)
 
S-1 : 10:30-12:00 | Free of Charge
Healthcare in 2025 - Opportunities and risks for pharma/med. Tech companies in the global business environment
Ms. Ivy Teh, Managing Director, EIU Helathcare/Clearstate Pte Ltd.
Economist Intelligence Unit (The Economist Group).

Thursday 21 April 2016

A-9 | 11:00-11:30 | Free of Charge
International Group Presentation (Spain)
Active pharmaceutical ingredients from Spain: A state of the art approach
ICEX ESPANA EXPORTACION E INVERIONES
 
K-6, 7, 8 | 11:00
International API Procurement Forum
“Secure Supply and Quality Control of APIs to meet requirements of the age of generic market share of 80%”
Organiser: Japan Pharmaceutical Traders’ Association
 
L-8 | 11:45-12:30 | Free of Charge
Reducing Risk in Novel and Complex Therapeutic API Manufacturing through Supply Chain Integration
Cynthia Wooge, Ph.D., Manager, Marketing Contract Manufacturing Services & Solutions
SAFC® (Sigma-Aldrich)
 
L-12 | 16:00-16:45 | Free of Charge
Recent Advances for Rapid Development of High-Quality, Robust Mammalian Cell Culture Biopharmaceutical Manufacturing Processes
Dr. Nicole O’Brien,Senior Director, Program Design,Fujifilm Diosynth Biotechnologies
 
J-10 | 15:15-16:15 | Free of Charge
Innovative drug delivery solutions for your (pipeline of) injectable biologics
Mr. Christian Herget, WW Strategic Marketing Leader Biotech,
Becton Dickinson BD Medical – Pharmaceutical Systems
 
D-13 | 14:30-15:30 | Free of Charge
Innovations in aseptic SVP filling– preservative-free multidose eye-drops /vaccine filling with coolBFS
Dr. Michael W. Spallek, general manager of R&D, rommelag

Friday 22 April 2016

L-14 | 11:30-12:00 | Free of Charge
Biosafety Trends in Bioprocessing
Dr. Junseok Kim,Associate Technical Director,BioProduction, Thermo Fisher Scientific Inc.